Sophia Competitors

Stocks . USA . 
Stock . Sophia Genetics SA
SOPH Stock  USD 4.31  0.09  2.13%   
Sophia Genetics SA competes with Thrivent High, Morningstar Unconstrained, Via Renewables, T Rowe, and Sitka Gold; as well as few others. The company conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Sophia Genetics competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Sophia Genetics to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Sophia Genetics Correlation with its peers.

Sophia Genetics vs Sycamore Entmt Correlation

Good diversification

The correlation between Sophia Genetics SA and SEGI is -0.12 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sophia Genetics SA and SEGI in the same portfolio, assuming nothing else is changed.

Moving together with Sophia Stock

  0.82OM Outset MedicalPairCorr

Moving against Sophia Stock

  0.67SPEC Inspecs Group plcPairCorr
The current Return On Tangible Assets is estimated to decrease to -0.47. The current Return On Capital Employed is estimated to decrease to -0.49. As of now, Sophia Genetics' Debt To Assets are increasing as compared to previous years.
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
1.114.237.35
Details
Intrinsic
Valuation
LowRealHigh
1.794.918.03
Details
Naive
Forecast
LowNextHigh
1.174.297.41
Details
6 Analysts
Consensus
LowTargetHigh
6.987.678.51
Details

Sophia Genetics Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Sophia Genetics and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Sophia and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Sophia Genetics SA does not affect the price movement of the other competitor.

High positive correlations

OSHDF
+ 1.0
ONCSQ
RRTLX
+ 0.97
MSTSX
RRTLX
+ 0.94
VIASP
VIASP
+ 0.9
LBHIX
VIASP
+ 0.9
MSTSX
RRTLX
+ 0.87
LBHIX
  

High negative correlations

SEGI
- 0.7
LBHIX
SEGI
- 0.69
VIASP
SEGI
- 0.65
RRTLX
SEGI
- 0.63
MSTSX
SEGI
- 0.56
RWAYL
SITKF
- 0.28
LBHIX

Risk-Adjusted Indicators

There is a big difference between Sophia Stock performing well and Sophia Genetics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sophia Genetics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ONCSQ  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
LBHIX  0.12  0.03  0.01  0.37  0.00 
(0.22)
 0.24 
(0.17)
 2.15 
MSTSX  0.61  0.18  0.23  0.28  0.29 
(0.72)
 0.91 
(0.89)
 12.34 
VIASP  0.30  0.03 (0.01)(21.68) 0.32 
(0.33)
 0.64 
(0.70)
 1.72 
RRTLX  0.26  0.05  0.08  0.20  0.09 
(0.33)
 0.47 
(0.46)
 3.36 
WQTM  1.69  0.04  0.03  0.06  1.98 
(1.70)
 3.22 
(3.22)
 9.00 
OSHDF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
SITKF  2.68  0.16  0.04  0.16  2.96 
(3.49)
 7.81 
(5.88)
 17.28 
RWAYL  0.11  0.02 (0.08)(0.84) 0.00 
(0.14)
 0.24 
(0.20)
 0.88 
SEGI  11.44  1.06  0.04  1.76  11.88 
(30.13)
 33.33 
(25.00)
 58.33 

Sophia Genetics Competitive Analysis

The better you understand Sophia Genetics competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Sophia Genetics' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Sophia Genetics' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
SOPH ONCSQ LBHIX MSTSX VIASP RRTLX WQTM OSHDF SITKF RWAYL
 2.13 
 4.31 
Sophia
 0.00 
 0.0001 
OncoSec
 0.23 
 17.16 
Thrivent
 0.44 
 11.31 
Morningstar
 0.94 
 25.40 
Via
 0.23 
 12.94 
RRTLX
 3.36 
 26.20 
WisdomTree
 0.00 
 0.04 
Oshidori
 1.32 
 0.77 
Sitka
 0.16 
 25.15 
MSCI
Market Volatility
(90 Days Market Risk)
Slightly risky
Very steady
Very steady
Not too volatile
Very steady
Very steady
Very steady
Very steady
Abnormally volatile
Very steady
Market Performance
(90 Days Performance)
Weakest
Weakest
Fair
Good
Fair
Good
Weakest
Weakest
Soft
Solid
Odds of Financial Distress
(Probability Of Bankruptcy)
Moderate
Unknown
Low
Low
Moderate
Low
Fair
High
High
Low
Current Valuation
(Equity Enterprise Value)
Under Valued
Over Valued
Over Valued
Under Valued
Fairly Valued
Fairly Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Strong Buy
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Strong Sell
Trade Advice
(90 Days Macroaxis Advice)
Sell
Strong Sell
Strong Sell
Strong Buy
Sell
Strong Hold
Cautious Hold
Strong Sell
Strong Sell
Strong Sell
Current Ratio
7.58
N/A
N/A
N/A
3.49
N/A
N/A
N/A
4.24
N/A
Net Asset
155.31 M
N/A
797.1 M
116.1 M
355.28 M
1.46 B
N/A
6.31 B
13.41 M
N/A
EBITDA
(50.76 M)
N/A
N/A
N/A
33.09 M
N/A
N/A
(3.49 B)
(1.57 M)
N/A
Operating Margin
-0.92
N/A
N/A
N/A
-0.14
N/A
N/A
1.04
N/A
N/A
Five Year Return
N/A
N/A
4.12
9.57
8.97
0.0406
N/A
N/A
N/A
N/A
One Year Return
N/A
N/A
7.75
17.24
N/A
0.067
N/A
N/A
N/A
N/A
Beta
1.14
N/A
N/A
N/A
1.16
N/A
N/A
0.67
1.45
N/A
Number Of Employees
423
N/A
1
1
169
1
N/A
31
1
N/A
Three Year Return
N/A
N/A
8.79
14.77
N/A
0.0491
N/A
N/A
N/A
N/A
Cash Flow From Operations
(42.82 M)
N/A
N/A
N/A
12.7 M
N/A
N/A
499.26 M
(1.27 M)
N/A
Total Debt
30.03 M
N/A
N/A
N/A
135 M
N/A
N/A
N/A
40 K
N/A
Bond Positions Weight
N/A
N/A
92.23
22.72
N/A
14.43
N/A
N/A
N/A
N/A
Holdings Turnover
N/A
N/A
N/A
269.0
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.26
N/A
N/A
N/A
-0.11
N/A
N/A
-0.46
-0.033
N/A
Current Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt To Equity
0.073
N/A
N/A
N/A
0.69
N/A
N/A
N/A
0.002
N/A
Short Ratio
0.68
N/A
N/A
N/A
0.7
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
50.42
N/A
N/A
N/A
N/A
N/A
N/A
0.84
10.92
N/A
Market Capitalization
278.17 M
N/A
N/A
50.36 M
N/A
N/A
N/A
233.49 M
12.62 M
N/A
Price To Earning
N/A
N/A
35.48
N/A
26.83
18.25
N/A
N/A
N/A
N/A
Price To Sales
3.8
N/A
1.23
N/A
N/A
1.57
N/A
N/A
N/A
N/A
Net Income
(61.27 M)
N/A
N/A
N/A
5.2 M
N/A
N/A
(3.15 B)
(1.28 M)
N/A
Shares Owned By Insiders
6.43
N/A
N/A
N/A
N/A
N/A
N/A
30.28
5.97
N/A
Revenue
65.17 M
N/A
N/A
N/A
393.49 M
N/A
N/A
(3.1 B)
N/A
N/A
Year To Date Return
N/A
N/A
1.0
4.46
N/A
-0.0211
N/A
N/A
N/A
N/A
Working Capital
72.6 M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Profit Margin
-1.02
N/A
N/A
N/A
0.0094
N/A
N/A
N/A
N/A
N/A
Current Valuation
297.25 M
N/A
N/A
N/A
535.95 M
N/A
N/A
103.84 M
8.05 M
N/A
Price To Book
5.2
N/A
1.58
N/A
N/A
2.13
N/A
0.005
1.1
N/A
Retained Earnings
(440.28 M)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Asset
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash Position Weight
N/A
N/A
6.56
14.28
N/A
7.22
N/A
N/A
N/A
N/A
Equity Positions Weight
N/A
N/A
0.07
61.63
N/A
38.52
N/A
N/A
N/A
N/A
Shares Outstanding
67.85 M
N/A
N/A
N/A
N/A
N/A
N/A
6.11 B
159.12 M
N/A
Annual Yield
N/A
N/A
0.0619
0.0218
0.0972
0.0283
N/A
N/A
N/A
N/A
Return On Equity
-0.86
N/A
N/A
N/A
0.017
N/A
N/A
-0.5
-0.0611
N/A
Z Score
N/A
N/A
N/A
N/A
1.0
N/A
N/A
N/A
N/A
N/A
Number Of Shares Shorted
226.05 K
N/A
N/A
N/A
4.29 K
N/A
N/A
N/A
N/A
2.19 K
Book Value Per Share
0.89
N/A
N/A
N/A
3.66
N/A
N/A
0.89
0.1
N/A
Minimum Initial Investment
N/A
N/A
2 K
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Asset
155.31 M
N/A
491.38 M
215.11 M
355.28 M
1.03 B
N/A
6.31 B
13.41 M
N/A
Target Price
7.67
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Last Dividend Paid
N/A
N/A
0.02
N/A
0.73
0.14
N/A
N/A
N/A
N/A
Earnings Per Share
-1.12
N/A
N/A
N/A
1.17
N/A
N/A
N/A
-0.01
N/A
Ten Year Return
N/A
N/A
6.0
N/A
N/A
5.76
N/A
N/A
N/A
N/A
Cash And Equivalents
216.61 M
N/A
N/A
N/A
51.31 M
N/A
N/A
N/A
5.77 M
N/A
Cash Per Share
3.38
N/A
N/A
N/A
3.23
N/A
N/A
N/A
0.04
N/A
Gross Profit
49.49 M
N/A
N/A
N/A
74.67 M
N/A
N/A
(4.09 B)
N/A
N/A
Day Typical Price
4.28
1.0E-4
17.16
11.31
25.48
12.94
26.2
0.036
0.77
25.14
Accumulation Distribution
0.0209
N/A
N/A
N/A
218.24
N/A
N/A
N/A
2017.69
0.0056
Market Facilitation Index
0.09
N/A
N/A
N/A
0.0
N/A
N/A
N/A
N/A
0.14
Daily Balance Of Power
1.0
0.0
9.2 T
9.2 T
(0.96)
9.2 T
0
0.0
0.5
0.2857
Period Momentum Indicator
0.09
N/A
0.04
0.05
(0.24)
0.03
(0.91)
N/A
0.01
0.04
Rate Of Daily Change
1.02
1.0
1.0
1.0
0.99
1.0
0.97
1.0
1.01
1.0
Day Median Price
4.26
1.0E-4
17.16
11.31
25.52
12.94
26.2
0.036
0.77
25.13
Price Action Indicator
0.09
N/A
0.02
0.025
(0.24)
0.015
(0.46)
N/A
0.005
0.04
Relative Strength Index
83.22
N/A
87.89
15.52
38.06
17.45
28.12
N/A
11.5
81.39
Coefficient Of Variation
(1,644)
N/A
587.47
668.5
1012.66
573.09
1956.28
N/A
1748.72
457.82
Mean Deviation
2.28
N/A
0.1243
0.6064
0.2975
0.2566
1.69
N/A
2.68
0.1113
Jensen Alpha
(0.26)
N/A
0.0319
0.1825
0.0282
0.0529
0.0428
N/A
0.157
0.0233
Total Risk Alpha
(0.34)
N/A
0.0231
0.1418
0.0106
0.0448
0.0019
N/A
0.0332
0.0157
Sortino Ratio
N/A
N/A
0.0093
0.2306
(0.01)
0.0817
0.03
N/A
0.0449
(0.08)
Downside Variance
N/A
N/A
0.0119
0.5682
0.1698
0.1342
4.29
N/A
13.61
0.0211
Standard Deviation
3.08
N/A
0.2653
1.46
0.3867
0.4245
2.08
N/A
3.67
0.1483
Kurtosis
1.99
N/A
39.31
44.86
0.0827
16.47
(0.35)
N/A
1.3
1.48
Potential Upside
4.35
N/A
0.2356
0.9137
0.6405
0.4724
3.22
N/A
7.81
0.2417
Treynor Ratio
(0.11)
N/A
0.3651
0.2784
(21.68)
0.1963
0.0614
N/A
0.1591
(0.84)
Maximum Drawdown
17.91
N/A
2.15
12.34
1.72
3.36
9.0
N/A
17.28
0.8772
Variance
9.51
N/A
0.0704
2.12
0.1495
0.1802
4.33
N/A
13.47
0.022
Market Risk Adjusted Performance
(0.10)
N/A
0.3751
0.2884
(21.67)
0.2063
0.0714
N/A
0.1691
(0.83)
Risk Adjusted Performance
(0.04)
N/A
0.1096
0.1173
0.0648
0.1235
0.0448
N/A
0.0509
0.1235
Skewness
(0.68)
N/A
5.68
6.09
(0.20)
2.74
0.1798
N/A
0.6198
0.259
Semi Deviation
N/A
N/A
0.0
0.2859
0.3209
0.0866
1.98
N/A
2.96
0.0
Information Ratio
(0.08)
N/A
0.0038
0.1193
(0.02)
0.0705
0.0299
N/A
0.0452
(0.08)
Value At Risk
(5.54)
N/A
(0.17)
(0.89)
(0.70)
(0.46)
(3.22)
N/A
(5.88)
(0.20)
Expected Short fall
N/A
N/A
(0.22)
(0.72)
(0.33)
(0.33)
(1.70)
N/A
(3.49)
(0.14)
Downside Deviation
N/A
N/A
0.1092
0.7538
0.4121
0.3664
2.07
N/A
3.69
0.1453
Semi Variance
N/A
N/A
(0.04)
0.0817
0.103
0.0075
3.91
N/A
8.74
(0.02)

Sophia Genetics Competition Performance Charts

Five steps to successful analysis of Sophia Genetics Competition

Sophia Genetics' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Sophia Genetics SA in relation to its competition. Sophia Genetics' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Sophia Genetics in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Sophia Genetics' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Sophia Genetics SA, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Sophia Genetics position

In addition to having Sophia Genetics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Macroaxis Picks Thematic Idea Now

Macroaxis Picks
Macroaxis Picks Theme
Daily selected watch list of stocks of large companies handpicked by Macroaxis Team based on their diversification potential. The Macroaxis Picks theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Picks Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Sophia Genetics SA offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sophia Genetics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sophia Genetics Sa Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sophia Genetics Sa Stock:
How To Invest In Sophia
Details
Is Sophia Stock a good investment?
Details
What is Sophia Genetics' Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out Sophia Genetics Correlation with its peers.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is there potential for Health Care Equipment & Supplies market expansion? Will Sophia introduce new products? Factors like these will boost the valuation of Sophia Genetics. If investors know Sophia will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Sophia Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.12)
Revenue Per Share
1.092
Quarterly Revenue Growth
0.228
Return On Assets
(0.26)
Return On Equity
(0.86)
The market value of Sophia Genetics SA is measured differently than its book value, which is the value of Sophia that is recorded on the company's balance sheet. Investors also form their own opinion of Sophia Genetics' value that differs from its market value or its book value, called intrinsic value, which is Sophia Genetics' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Sophia Genetics' market value can be influenced by many factors that don't directly affect Sophia Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Sophia Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sophia Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Sophia Genetics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY